Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Transdermal fentanyl: long-term analgesic studies.

Simmonds MA, Richenbacher J.

J Pain Symptom Manage. 1992 Apr;7(3 Suppl):S36-9. Review.

PMID:
1517630
2.

A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain.

Sloan PA, Moulin DE, Hays H.

J Pain Symptom Manage. 1998 Aug;16(2):102-11.

PMID:
9737101
3.

Transdermal fentanyl: clinical development in the United States.

Simmonds MA.

Anticancer Drugs. 1995 Apr;6 Suppl 3:35-8.

PMID:
7606034
4.
5.

Evaluation of safety and efficacy of transdermal therapeutic system-fentanyl in adult patients with gynecological cancer-related pain.

Lorvidhaya V, Katanyoo K, Srisomboon J, Suprapaphorn P, Cheewakriangkrai C.

J Med Assoc Thai. 2004 Mar;87(3):319-25.

PMID:
15117050
6.
8.

Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.

Clark AJ, Ahmedzai SH, Allan LG, Camacho F, Horbay GL, Richarz U, Simpson K.

Curr Med Res Opin. 2004 Sep;20(9):1419-28.

PMID:
15383190
9.

Long-term treatment of cancer pain with transdermal fentanyl.

Donner B, Zenz M, Strumpf M, Raber M.

J Pain Symptom Manage. 1998 Mar;15(3):168-75.

PMID:
9564118
10.

Transdermal fentanyl: seeding trial in patients with chronic cancer pain.

Levy MH, Rosen SM, Kedziera P.

J Pain Symptom Manage. 1992 Apr;7(3 Suppl):S48-50.

PMID:
1517633
11.

Transdermal fentanyl for pain control in patients with cancer.

Miser AW, Narang PK, Dothage JA, Young RC, Sindelar W, Miser JS.

Pain. 1989 Apr;37(1):15-21.

PMID:
2726274
12.
13.

Transdermal fentanyl therapy: system design, pharmacokinetics and efficacy.

Southam MA.

Anticancer Drugs. 1995 Apr;6 Suppl 3:29-34. Review.

PMID:
7606033
14.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
15.

Efficacy, safety and pharmacokinetic study of a novel fentanyl-containing matrix transdermal patch system in Japanese patients with cancer pain.

Miyazaki T, Hanaoka K, Namiki A, Ogawa S, Kitajima T, Hosokawa T, Ishida T, Nogami S, Mashimo S.

Clin Drug Investig. 2008;28(5):313-25.

PMID:
18407717
16.

Inter- and intraindividual variabilities in pharmacokinetics of fentanyl after repeated 72-hour transdermal applications in cancer pain patients.

Solassol I, Bressolle F, Caumette L, Garcia F, Poujol S, Culine S, Pinguet F.

Ther Drug Monit. 2005 Aug;27(4):491-8.

PMID:
16044107
19.

Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids.

Mystakidou K, Befon S, Tsilika E, Dardoufas K, Georgaki S, Vlahos L.

Oncology. 2002;62(1):9-16.

PMID:
11810038
20.

A safe and effective method for converting patients from transdermal to intravenous fentanyl for the treatment of acute cancer-related pain.

Kornick CA, Santiago-Palma J, Schulman G, O'Brien PC, Weigand S, Payne R, Manfredi PL.

Cancer. 2003 Jun 15;97(12):3121-4.

Supplemental Content

Support Center